ArticleCardiovascular diabetology2020

Marked effects of novel selective peroxisome proliferator-activated receptor α modulator, pemafibrate in severe hypertriglyceridemia: preliminary report.

Chie Iitake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.